| Target Price | €146.88 |
| Price | €67.40 |
| Potential |
117.92%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Redcare Pharmacy 2027 .
The average Redcare Pharmacy target price is €146.88.
This is
117.92%
register free of charge
€224.70
233.38%
register free of charge
€74.74
10.89%
register free of charge
|
|
| A rating was issued by 15 analysts: 11 Analysts recommend Redcare Pharmacy to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Redcare Pharmacy stock has an average upside potential 2027 of
117.92%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 2.37 | 3.00 |
| 31.79% | 26.68% | |
| EBITDA Margin | 1.26% | 2.13% |
| 54.51% | 69.55% | |
| Net Margin | -1.92% | -0.62% |
| 186.50% | 67.67% |
12 Analysts have issued a sales forecast Redcare Pharmacy 2025 . The average Redcare Pharmacy sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Redcare Pharmacy EBITDA forecast 2025. The average Redcare Pharmacy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Redcare Pharmacy Analysts have issued a net profit forecast 2025. The average Redcare Pharmacy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -2.27 | -0.92 |
| 260.32% | 59.47% | |
| P/E | negative | |
| EV/Sales | 0.49 |
12 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy EPS is
This results in the following potential growth metrics and future valuations:
Redcare Pharmacy...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Dec 04 2025 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Nov 28 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Dec 04 2025 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Nov 28 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 09 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


